Cambridge Nutritional Sciences (LSE:CNSL) ROE % Adjusted to Book Value : -4.39% (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Cambridge Nutritional Sciences ROE % Adjusted to Book Value?

Cambridge Nutritional Sciences's ROE % for the quarter that ended in Sep. 2024 was -4.08%. Cambridge Nutritional Sciences's PB Ratio for the quarter that ended in Sep. 2024 was 0.93. Cambridge Nutritional Sciences's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -4.39%.

Cambridge Nutritional Sciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Cambridge Nutritional Sciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambridge Nutritional Sciences ROE % Adjusted to Book Value Chart

Cambridge Nutritional Sciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-50.52

-1.81

-109.14

-47.93

-3.98

Cambridge Nutritional Sciences Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-75.21	-44.05	-28.45	9.29	-4.39

Competitive Comparison of Cambridge Nutritional Sciences's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cambridge Nutritional Sciences's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Cambridge Nutritional Sciences ROE % Adjusted to Book Value Calculation

Cambridge Nutritional Sciences's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-3.34%	/	0.84
	=	-3.98%

Cambridge Nutritional Sciences's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-4.08%	/	0.93
	=	-4.39%

Cambridge Nutritional Sciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cambridge Nutritional Sciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cambridge Nutritional Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cambridge Nutritional Sciences PLC (LSE:CNSL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Fleet Place, London, GBR, EC4M 7WS

Website

https://www.cnsplc.com

Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition division specialises in the research, development, and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis to the general public, clinics, and health professionals as well as supplying the point-of-care Food Detective test. The Corporate segment consists of centralised corporate costs which are not allocated to the trading activities of the group. The company generates the majority of its revenue from the Health and Nutrition segment.